Skip to main content
Top
Published in: Supportive Care in Cancer 7/2021

01-07-2021 | Lung Cancer | Original Article

End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysis

Authors: Amy J. Davidoff, Maureen E. Canavan, Elizabeth Prsic, Maureen Saphire, Shi-Yi Wang, Carolyn J. Presley

Published in: Supportive Care in Cancer | Issue 7/2021

Login to get access

Abstract

Background

Rather than early hospice enrollment, most Medicare beneficiaries receive “usual care” in the last months of life, outside of the hospice setting. While care intensity during the last weeks of life has been studied extensively, patterns of symptom management services (SMS) and/or cancer-directed therapies (CDT) received over a 6-month end-of-life period have not.

Methods

This retrospective study used the Surveillance, Epidemiology, and End Results (SEER)–Medicare database to identify decedents diagnosed with lung cancer at age ≥ 66 years between January 2007 and December 2013 who survived ≥ 6 months from diagnosis. Medicare claims identified receipt of SMS and/or CDT. We created monthly indicators for care content (SMS-only, CDT-only, or both; otherwise full-month hospice or inpatient/skilled nursing). Multinomial logistic regression estimated associations between sociodemographics and comorbidity, with care content in the final month.

Results

Between 6 and 1 months before death, full-month hospice and inpatient/skilled nursing increased; CDT decreased from 31.9 to 18.5%; SMS increased from 86.6 to 97.7%. Relative to full-month hospice, the percentage of patients receiving SMS-only was higher for males, unmarried, younger age, and higher comorbidity; the percentage receiving CDT was also higher for males, unmarried, and younger age, but decreased with increasing comorbidity and over calendar time.

Conclusion

Among lung cancer decedents observed in the outpatient, nonhospice setting, SMS receipt increased and was nearly universal as death approached. CDT diminished dramatically over the end-of-life period. Associations between sociodemographic characteristics and care setting suggest differences in care preferences or access barriers. Claims represent an important resource for characterizing end-of-life care patterns.
Appendix
Available only for authorised users
Literature
2.
go back to reference National Hospice and Palliative Care Organization (2015) NHPCO’s facts and figures. Hospice Care in America, Alexandria, VA National Hospice and Palliative Care Organization (2015) NHPCO’s facts and figures. Hospice Care in America, Alexandria, VA
3.
go back to reference Aldridge Carlson MD, Barry CL, Cherlin EJ, McCorkle R, Bradley EH (2012) Hospices’ enrollment policies may contribute to underuse of hospice care in the United States. Health Aff (Project Hope) 31:2690–2698CrossRef Aldridge Carlson MD, Barry CL, Cherlin EJ, McCorkle R, Bradley EH (2012) Hospices’ enrollment policies may contribute to underuse of hospice care in the United States. Health Aff (Project Hope) 31:2690–2698CrossRef
4.
go back to reference Wang SY, Hall J, Pollack CE, Adelson K, Bradley EH, Long JB, Gross CP (2016) Trends in end-of-life cancer care in the Medicare program. J Geriatr Oncol 7:116–125CrossRef Wang SY, Hall J, Pollack CE, Adelson K, Bradley EH, Long JB, Gross CP (2016) Trends in end-of-life cancer care in the Medicare program. J Geriatr Oncol 7:116–125CrossRef
5.
go back to reference Drageset J, Corbett A, Selbaek G, Husebo BS (2014) Cancer-related pain and symptoms among nursing home residents: a systematic review. J Pain Symptom Manag 48:699–710 e691CrossRef Drageset J, Corbett A, Selbaek G, Husebo BS (2014) Cancer-related pain and symptoms among nursing home residents: a systematic review. J Pain Symptom Manag 48:699–710 e691CrossRef
6.
go back to reference Duncan JG, Forbes-Thompson S, Bott MJ (2008) Unmet symptom management needs of nursing home residents with cancer. Cancer Nurs 31:265–273CrossRef Duncan JG, Forbes-Thompson S, Bott MJ (2008) Unmet symptom management needs of nursing home residents with cancer. Cancer Nurs 31:265–273CrossRef
7.
go back to reference Hunnicutt JN, Tjia J, Lapane KL (2017) Hospice use and pain management in elderly nursing home residents with cancer. J Pain Symptom Manag 53:561–570CrossRef Hunnicutt JN, Tjia J, Lapane KL (2017) Hospice use and pain management in elderly nursing home residents with cancer. J Pain Symptom Manag 53:561–570CrossRef
8.
go back to reference Horton JR, Morrison RS, Capezuti E, Hill J, Lee EJ, Kelley AS (2016) Impact of inpatient palliative care on treatment intensity for patients with serious illness. J Palliat Med 19:936–942CrossRef Horton JR, Morrison RS, Capezuti E, Hill J, Lee EJ, Kelley AS (2016) Impact of inpatient palliative care on treatment intensity for patients with serious illness. J Palliat Med 19:936–942CrossRef
9.
go back to reference Sharma RK, Cameron KA, Chmiel JS, von Roenn JH, Szmuilowicz E, Prigerson HG, Penedo FJ (2015) Racial/ethnic differences in inpatient palliative care consultation for patients with advanced cancer. J Clin Oncol 33:3802–3808CrossRef Sharma RK, Cameron KA, Chmiel JS, von Roenn JH, Szmuilowicz E, Prigerson HG, Penedo FJ (2015) Racial/ethnic differences in inpatient palliative care consultation for patients with advanced cancer. J Clin Oncol 33:3802–3808CrossRef
10.
go back to reference Dwyer LL, Lau DT, Shega JW (2015) Medications that older adults in hospice care in the United States Take, 2007. J Am Geriatr Soc 63:2282–2289CrossRef Dwyer LL, Lau DT, Shega JW (2015) Medications that older adults in hospice care in the United States Take, 2007. J Am Geriatr Soc 63:2282–2289CrossRef
11.
go back to reference Dincer M, Kahveci K, Doger C (2018) An examination of factors affecting the length of stay in a palliative care center. J Palliat Med 21:11–15CrossRef Dincer M, Kahveci K, Doger C (2018) An examination of factors affecting the length of stay in a palliative care center. J Palliat Med 21:11–15CrossRef
12.
go back to reference Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW (2010) Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J 160:139–144CrossRef Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW (2010) Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J 160:139–144CrossRef
13.
go back to reference Saphire ML, Prsic EH, Canavan ME, Wang SJ, Presley CJ, Davidoff AJ (2020) Patterns of symptom management medication receipt at end-of-life among medicare beneficiaries with lung cancer. J Pain Symptom Manage 59(4):767–777CrossRef Saphire ML, Prsic EH, Canavan ME, Wang SJ, Presley CJ, Davidoff AJ (2020) Patterns of symptom management medication receipt at end-of-life among medicare beneficiaries with lung cancer. J Pain Symptom Manage 59(4):767–777CrossRef
14.
go back to reference Warren JL, Barbera L, Bremner KE, Yabroff KR, Hoch JS, Barrett MJ, Luo J, Krahn MD (2011) End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst 103:853–862CrossRef Warren JL, Barbera L, Bremner KE, Yabroff KR, Hoch JS, Barrett MJ, Luo J, Krahn MD (2011) End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst 103:853–862CrossRef
15.
go back to reference Tanuseputro P, Budhwani S, Bai YQ, Wodchis WP (2017) Palliative care delivery across health sectors: a population-level observational study. Palliat Med 31:247–257CrossRef Tanuseputro P, Budhwani S, Bai YQ, Wodchis WP (2017) Palliative care delivery across health sectors: a population-level observational study. Palliat Med 31:247–257CrossRef
16.
go back to reference Tanuseputro P, Beach S, Chalifoux M, Wodchis WP, Hsu AT, Seow H, Manuel DG (2018) Associations between physician home visits for the dying and place of death: a population-based retrospective cohort study. PLoS One 13:e0191322CrossRef Tanuseputro P, Beach S, Chalifoux M, Wodchis WP, Hsu AT, Seow H, Manuel DG (2018) Associations between physician home visits for the dying and place of death: a population-based retrospective cohort study. PLoS One 13:e0191322CrossRef
17.
go back to reference Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 109(9):djx030 Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, Mariotto A, Lake AJ, Wilson R, Sherman RL, Anderson RN, Henley SJ, Kohler BA, Penberthy L, Feuer EJ, Weir HK (2017) Annual report to the nation on the status of cancer, 1975–2014, featuring survival. J Natl Cancer Inst 109(9):djx030
18.
go back to reference Cooley ME, Short TH, Moriarty HJ (2003) Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 12:694–708CrossRef Cooley ME, Short TH, Moriarty HJ (2003) Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer. Psychooncology 12:694–708CrossRef
19.
go back to reference Sung MR, Patel MV, Djalalov S, le LW, Shepherd FA, Burkes RL, Feld R, Lin S, Tudor R, Leighl NB (2017) Evolution of symptom burden of advanced lung cancer over a decade. Clin Lung Cancer 18:274–280 e276CrossRef Sung MR, Patel MV, Djalalov S, le LW, Shepherd FA, Burkes RL, Feld R, Lin S, Tudor R, Leighl NB (2017) Evolution of symptom burden of advanced lung cancer over a decade. Clin Lung Cancer 18:274–280 e276CrossRef
20.
go back to reference Warren JL, Klabunde CN, Schrag D et al (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18PubMed Warren JL, Klabunde CN, Schrag D et al (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:IV-3-18PubMed
21.
go back to reference Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D (2014) Survivorship: pain version 1.2014. J Natl Compr Cancer Netw 12:488–500CrossRef Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL, Goldman M, Jones L, King A, Ku GH, Kvale E, Langbaum TS, Leonardi-Warren K, McCabe MS, Melisko M, Montoya JG, Mooney K, Morgan MA, Moslehi JJ, O’Connor T, Overholser L, Paskett ED, Raza M, Syrjala KL, Urba SG, Wakabayashi MT, Zee P, McMillian N, Freedman-Cass D (2014) Survivorship: pain version 1.2014. J Natl Compr Cancer Netw 12:488–500CrossRef
22.
go back to reference National Comprehensive Cancer Network (2019) Palliative Care. NCCN Clinical Practice Guidelines in Oncology: NCCN National Comprehensive Cancer Network (2019) Palliative Care. NCCN Clinical Practice Guidelines in Oncology: NCCN
23.
go back to reference Check DK, Rosenstein DL, Dusetzina SB (2016) Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer. Support Care Cancer 24:3463–3472CrossRef Check DK, Rosenstein DL, Dusetzina SB (2016) Early supportive medication use and end-of-life care among Medicare beneficiaries with advanced breast cancer. Support Care Cancer 24:3463–3472CrossRef
24.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM (1998) Comorbidity measures for use with administrative data. Med Care 36:8–27CrossRef
26.
go back to reference Spencer KL, Mrig EH, Talaie AK (2020) Does palliative care utilization facilitate conversion to hospice care? A qualitative study of the “Soft No”. Am J Hosp Palliat Care 37:701–706CrossRef Spencer KL, Mrig EH, Talaie AK (2020) Does palliative care utilization facilitate conversion to hospice care? A qualitative study of the “Soft No”. Am J Hosp Palliat Care 37:701–706CrossRef
27.
go back to reference Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ (2006) Variations in hospice use among cancer patients. J Natl Cancer Inst 98:1053–1059CrossRef Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ (2006) Variations in hospice use among cancer patients. J Natl Cancer Inst 98:1053–1059CrossRef
28.
go back to reference Sullivan DR, Ganzini L, Lapidus JA, Hansen L, Carney PA, Osborne ML, Fromme EK, Izumi S, Slatore CG (2018) Improvements in hospice utilization among patients with advanced-stage lung cancer in an integrated health care system. Cancer 124:426–433CrossRef Sullivan DR, Ganzini L, Lapidus JA, Hansen L, Carney PA, Osborne ML, Fromme EK, Izumi S, Slatore CG (2018) Improvements in hospice utilization among patients with advanced-stage lung cancer in an integrated health care system. Cancer 124:426–433CrossRef
29.
go back to reference McDermott CL, Engelberg RA, Woo C et al (2019) Novel data linkages to characterize palliative and end-of-life care: challenges and considerations. J Pain Symptom Manag 58:851–856CrossRef McDermott CL, Engelberg RA, Woo C et al (2019) Novel data linkages to characterize palliative and end-of-life care: challenges and considerations. J Pain Symptom Manag 58:851–856CrossRef
30.
go back to reference U S Centers for Medicare & Medicaid Services (2015) Medicare care choices model enables concurrent palliative and curative care. J Pain Palliat Care Pharmacother 29(4):401–403CrossRef U S Centers for Medicare & Medicaid Services (2015) Medicare care choices model enables concurrent palliative and curative care. J Pain Palliat Care Pharmacother 29(4):401–403CrossRef
Metadata
Title
End-of-life patterns of symptom management and cancer-directed care among Medicare beneficiaries with lung cancer: a claims-based analysis
Authors
Amy J. Davidoff
Maureen E. Canavan
Elizabeth Prsic
Maureen Saphire
Shi-Yi Wang
Carolyn J. Presley
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 7/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05964-2

Other articles of this Issue 7/2021

Supportive Care in Cancer 7/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine